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Abstract
High throughput sequencing has accelerated the determination of genome sequences for thousands of human infectious
disease pathogens and dozens of their vectors. The scale and scope of these data are enabling genotype-phenotype
association studies to identify genetic determinants of pathogen virulence and drug/insecticide resistance, and
phylogenetic studies to track the origin and spread of disease outbreaks. To maximize the utility of genomic sequences
for these purposes, it is essential that metadata about the pathogen/vector isolate characteristics be collected and made
available in organized, clear, and consistent formats. Here we report the development of the GSCID/BRC Project and Sample
Application Standard, developed by representatives of the Genome Sequencing Centers for Infectious Diseases (GSCIDs),
the Bioinformatics Resource Centers (BRCs) for Infectious Diseases, and the U.S. National Institute of Allergy and Infectious
Diseases (NIAID), part of the National Institutes of Health (NIH), informed by interactions with numerous collaborating
scientists. It includes mapping to terms from other data standards initiatives, including the Genomic Standards Consortium’s
minimal information (MIxS) and NCBI’s BioSample/BioProjects checklists and the Ontology for Biomedical Investigations
(OBI). The standard includes data fields about characteristics of the organism or environmental source of the specimen,
spatial-temporal information about the specimen isolation event, phenotypic characteristics of the pathogen/vector
isolated, and project leadership and support. By modeling metadata fields into an ontology-based semantic framework and
reusing existing ontologies and minimum information checklists, the application standard can be extended to support
additional project-specific data fields and integrated with other data represented with comparable standards. The use of
this metadata standard by all ongoing and future GSCID sequencing projects will provide a consistent representation of
these data in the BRC resources and other repositories that leverage these data, allowing investigators to identify relevant
genomic sequences and perform comparative genomics analyses that are both statistically meaningful and biologically
relevant.
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Introduction
Microbial and invertebrate vector genomes, indeed genomes in
general, are being sequenced and deposited in public data
repositories at an increasingly rapid pace [1,2]. The scale and
scope of pathogen sequencing projects are enabling the investiga-
tion of genotype-phenotype relationships, including the elucidation
of genetic determinants of specific pathogen traits such as
virulence and drug resistance [3–5]. Similarly, vector population
genomic analyses are aiding in the development of novel control
and prevention approaches and insecticide discovery [6,7]. Rapid
genome sequencing and analysis also allows the tracking of the
origin and spread of new disease outbreaks in an unprecedented
manner [8]. These genomics-based studies are only feasible if each
sequence record is linked to meaningful metadata about the
sequenced specimen. Unfortunately, inconsistencies in how the
specimen source, clinical phenotypes, and sequence quality are
described pose a significant barrier to these scientific inquiries. By
standardizing metadata annotation and collection at the onset of a
project, biologically meaningful epidemiologic, phylogenetic, and
comparative genomic analyses can be performed [9]. Consistently
applied metadata standards are also essential for retrospective
study data integration and meta-analysis across studies. Future
prospective studies can be designed to collect similar metadata
fields to allow better integration with existing knowledge in the
field. Thus, establishing metadata standards promotes maximal
utility of the data generated and makes these data available for
uses beyond what may have been originally envisioned.
Recognizing the need for better standardization of sequence-
related metadata, the U.S. National Institute of Allergy and Infectious
Diseases (NIAID) established a working group with representatives
from NIAID, and the NIAID-funded Genomic Sequencing Centers
(GSCIDs) (http://www.niaid.nih.gov/labsandresources/resources/
dmid/gsc/Pages/default.aspx) and Bioinformatics Resource Centers
(BRCs) (http://www.niaid.nih.gov/labsandresources/resources/
dmid/brc/Pages/default.aspx) to develop an approach for capturing
standardized genome sequence metadata. The GSCIDs work
collaboratively with the research community to provide services for
rapid and cost efficient production of high-quality genome assemblies
and annotations, and high-throughput genotyping of NIAID
Category A–C priority pathogens, microorganisms responsible for
emerging and re-emerging infectious diseases, invertebrate vectors of
infectious diseases, and related organisms. The BRCs manage,
integrate, and display genome sequence data and annotation, as well
as other research data types, including other ‘‘-omics’’ data (e.g.
transcriptomics, proteomics, metabolomics), and data pertaining to
epidemiology, surveillance, population genetics, genotype/pheno-
type association, antimicrobial resistance, and antigenicity for these
pathogens and their vectors [10–15]. The BRCs also make available
bioinformatics tools and services for processing, analyzing, and
interpreting these data for further scientific investigation. The
collaborative environment cultivated by these NIAID-supported
projects presents a unique opportunity to ensure accurate and
consistent metadata collection from sample providers, and rapid,
transparent deposition of these data into publicly accessible resources,
ensuring the availability of the data and required tools for effective
mining and analysis of the sequence and associated metadata by the
broader scientific research community.
Here we report on a multi-project and multi-institutional effort
for the development of an approach for the capture of
standardized human pathogen and vector sequencing metadata
designed to support epidemiologic and genotype-phenotype
association studies.
Methods
In designing an approach for the capture of standardized
metadata two important factors needed to be considered - what
kind of information should be captured and how that information
should be represented. These considerations can be largely
addressed by specifying (i) a minimum set of data fields and (ii) the
controlled vocabularies or data dictionaries to be used as allowed values. The
data fields describe information about who performed the study,
where the samples came from, when the samples were isolated,
etc., for all sequencing projects, along the lines of the minimum
information checklists established by the MIBBI Consortium [16].
These are ideally derived from established minimum information
checklists, ensuring that the data is interoperable with data derived
from other sequencing initiatives. The controlled vocabularies
define the allowed values and acceptable formats for each data
field. They are ideally derived from existing biomedical ontologies,
ensuring that the same entities are described using the same
terminologies that include embedded semantic relationships.
Assembling Lists of Metadata Fields and Attributes
Beginning in May 2011, NIAID assembled a working group to
develop an approach for capturing standardized genome sequence
metadata – the GSCID-BRC Metadata Working Group. This
working group consisted of representatives from the three GSCIDs
– at the Broad Institute (http://www.broadinstitute.org/science/
projects/gscid/genomic-sequencing-center-infectious-diseases), the
J. Craig Venter Institute (http://gsc.jcvi.org), and the University of
Maryland, School of Medicine, Institute for Genome Sciences
(http://gscid.igs.umaryland.edu) - and the five Bioinformatics
Resource Centers (BRCs) - the Eukaryotic Pathogen Database
Resources (EuPathDB: http://EuPathDB.org), the Influenza Re-
search Database (IRD: http://www.fludb.org/), the Pathosystems
Resource Integration Center (PATRIC: http://patricbrc.org), the
Bioinformatics Resource for Invertebrate Vectors of Human
Pathogens (VectorBase: https://www.vectorbase.org), and the
Virus Pathogen Resource (ViPR: http://www.viprbrc.org/). Im-
portantly, the group focused on developing metadata standards that
was congruous with other standards to avoid adding additional
confusion to what has become a complicated landscape of
biomedical data standards. The adopted approach consisted of
developing an ‘‘application metadata standard’’, which was derived
through the collection of data fields and through mapping these
fields wherever possible to synonymous terms existing in established
‘‘reference data standards’’ and biomedical ontologies. We therefore
focused on developing a cross-compatible application standard to
capture the relevant information describing a sequencing project,
and then represent it in a standardized way. Such an approach
could be used to guide the collection, representation, transmission,
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submission, and search of metadata relating to GSCID and BRC
projects.
The process of developing the application standard began by
establishing subgroups based on various areas of expertise (i.e.
insect vector, eukaryotic pathogen, bacterial pathogen, and viral
pathogen). Each subgroup then reviewed various internal and
external sources of sequencing project and sample metadata to
identify terms that were relevant at either the project or sample
level. Names, descriptions, synonyms, allowed values, and other
information were compiled for each metadata term and each was
evaluated for its importance relating to data access and analysis
use cases. Existing ontologies were then identified to further
standardize the representation of the metadata fields. The separate
lists of project-level and sample-level fields from all subgroups were
then merged together and redundancy eliminated.
The final outcome of these efforts resulted in a set of metadata
fields and associated descriptive information organized as being
relevant to one of the following hierarchical groupings: core project
metadata (metadata that applies to all projects), core sample metadata
(metadata that applies to all samples), sequencing assay metadata,
pathogen-specific metadata, and project-specific metadata (Figure 1).
Submission of values for all core data fields would be required
for all sequencing projects, with ‘‘not available’’ accepted as an
allowed value for certain fields. Pathogen-specific and project-
specific data fields would be made available as pick lists to provide
additional optional information of relevance for a given project.
Semantic Representation and Harmonization with
Related Standards
As part of our effort to develop an application metadata
standard, a comprehensive evaluation was undertaken to evaluate
the degree of overlap between the draft collection of GSCID/BRC
metadata fields derived above and those supported in other
relevant data standards. As a result of this evaluation, the
Ontology for Biomedical Investigations (OBI) [17] was adopted
as the underlying framework because of its domain coverage, its
adoption by other database resources, and the value of using its
semantic formalism. OBI is the only member of OBO Foundry
[18] collection of ontologies that covers all aspects of a biomedical
investigation, and includes descriptions of the various protocols,
processes and participants used in research. By incorporating the
OBI ontology into the GSC/BRC metadata standard, the
information represented would be directly comparable with other
data represented using OBI and other OBO Foundry ontologies.
OBI is organized around processes used in biomedical
investigations. To place the draft metadata fields into the OBI
framework, we collaborated with OBI developers to first organize
the metadata fields into the following planned processes:
investigation, specimen collection, sequencing assay, and data analysis. Next,
corresponding OBI (or other OBO Foundry ontology) terms were
identified as either exact matches for a metadata field or as being
an ‘‘is_a’’ parent in the OBI ontological hierarchy. If an equivalent
term did not exist, a request was made to the OBI developers to
create a new ontology term by providing an OBI-compatible label,
a community preferred GSCID-BRC label as an exact synonym, a
textual description and a logical definition (including parent class)
to the OBI Issue Tracker for discussion and eventual adoption by
OBI developers. This process was repeated until each draft
GSCID-BRC data field was represented by an OBI (or other
OBO Foundry) term. Thus, while the official labels, definitions,
and unique identifiers of the data fields would be derived from the
OBI ontology, the community preferred labels and descriptions of
the draft metadata fields, which are both understandable and
intuitive to the infectious disease community, would also be
available. A graphical semantic representation was generated
using the cmap tools (http://cmap.ihmc.us) to visualize the Core
Project and Core Sample metadata fields as an ontological model.
After reviewing the modeled representation, a web ontology
language (OWL) file was generated as a GSCID/BRC View of
OBI and posted at the NCBO BioPortal ontology repository
website (http://bioportal.bioontology.org/ontologies/2127).
In addition, direct comparisons were made to identify
synonymous terms from the Minimum Information about any
(x) Sequence (MIxS) standard, which was developed by the
Genomic Standards Consortium [19], as well as the NCBI
BioProject and BioSample repositories [20] through an active
collaboration with representatives from these two initiatives. The
one-to-one mapping results between these existing standards and
our application standard were included in the GSCID/BRC core
metadata representation to facilitate cross-compatibility. MIxS
comparisons were reviewed and discussed with the Genomic
Standards Consortium to determine correctness. Feedback was
also solicited from NCBI regarding the metadata field mapping to
BioProject and BioSample as these would ultimately be used in the
submission process to the respective NCBI repositories. This
harmonization process identified additional metadata fields that
covered aspects of study design and were consequently added to
the core metadata representation prior to submission to the OBI
Issue Tracker for inclusion in OBI.
In this way, all data fields identified as being relevant for
pathogen/vector sequencing projects were represented with OBI
or other relevant OBO Foundry ontology (e.g. Environment
Ontology (EnvO)) terms, with mappings to equivalent terms in the
MIxS standard where appropriate, and all data required for NCBI
BioProject and BioSample registration were included in the
resulting ‘‘GSCID/BRC Project and Sample Application Stan-
dard’’. By providing this one-to-one mapping between these
related standards, data represented using the GSCID/BRC
Project and Sample Application Standard will be interoperable
with related data represented using these other relevant standards.
Evaluation and Refinement
Following the harmonization of metadata submission fields with
existing initiatives, initial versions of Core Project, Core Sample,
and Project-Specific metadata submission templates were estab-
lished for use with all GSCID and BRC related projects. A
metadata submission workflow was also defined to describe who
would be responsible for providing a given data field and at what
point the information would be provided in the sequencing and
submission process. The GSCID/BRC Project and Sample
Application Standard metadata submission templates (version
1.1) were then distributed to collaborating research scientists
working on bacterial, viral, eukaryotic and vector sequencing
projects for evaluation and feedback during a test submission.
Their feedback was evaluated and incorporated into a revised
version (1.2) of the Core Project and Core Sample data submission
templates.
Upon completing the list of terms comprising version 1.2 of the
GSCID-BRC standardized metadata collection, we again ap-
proached the personnel associated with the MIxS and NCBI data
standards initiatives to encourage the adoption of missing terms
while simultaneously ensuring the correctness of the mappings.
This exercise helped us identify 15 terms that were directly related
to a sequencing assay, and are either required fields associated
with a Sequence Read Archive (SRA) submission or structured
comments within a GenBank record. Consequently, these terms
were segregated from the Core Sample section and consolidated
into a new Sequencing Assay component to maintain its modular
Pathogen/Vector Genomic Sequence Metadata Standard
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structure, resulting in Version 1.3 of the GSCID/BRC Project and
Sample Application Standard. This workflow will ensure that the
Core Project and Core Sample fields can be universally applicable
regardless of the experimental assay used to produce the data, while
simultaneously ensuring their usefulness in downstream analyses
and maintaining compatibility with existing metadata standards. An
archive of current versions of the GSCID/BRC Project and Sample




Resulting GSCID/BRC Project and Sample Application
Standard
The resulting application standard comprises specific collections
of standardized metadata fields divided into sections (Figure 1).
Two sections are relevant to all pathogen/vector related research
projects and sample collections and are thus considered ‘‘core’’.
One section includes data fields of relevance to the sequencing
assay component of the workflow. Two sections are specific to a
Figure 1. NIAID GSCID/BRC Project and Sample Application Standard Overview. Coverage of the twelve major data categories in the five
data field collections is shown.
doi:10.1371/journal.pone.0099979.g001
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particular pathogen/vector category and are relevant to all
projects related to that pathogens/vectors category (pathogen
specific). One section includes fields that are project specific. A
summary of each of these sections follows:
A. The Core Project section includes 23 data fields that pertain to
the overall project/investigation. This section includes items
such as the project title, project rationale, contact information
for investigators, links to any related publications, etc.
(Table 1). Since all of these fields are relevant for any
pathogen/vector-related project, they are considered to be
‘‘core’’ and would be required fields for a complete
submission package. Ten of the 23 Core Project terms had
equivalents in BioProject or MIxS.
B. The Core Sample section contains 27 data fields grouped into
five categories describing host characterization (e.g. species,
age, sex and health status), specimen isolation (e.g. date and
geographic location of specimen collection, specimen type
and environmental source), pathogen detection (e.g. detected
pathogen and method of detection), pathogen characteriza-
tion (refers to the pathogenicity to humans), and specimen
processing (samples from biosample repositories and sample
identifier used by the source repository). Recognizing that
investigators may not find the anticipated pathogen or may
identify additional pathogens, the core sample section also
captures details about anticipated species and their pathoge-
nicity (Table 2). Since all of these fields are relevant for any
pathogen/vector-related project, they are considered to be
‘‘core’’ and would be required fields for a complete
submission package. The Core Sample terms had robust
mapping to OBI, BioSample and MIxS, and most had
equivalent OBO IDs.
Table 1. Core Project Attributes.
Field
ID Field Name Data Categories OBO Foundry URL
BioProject
Synonyms MIxS Synonym
CP1 Project Title Investigation http://purl.obolibrary.org/obo/OBI_0001622 Title* project name
CP2 Project ID Investigation http://purl.obolibrary.org/obo/OBI_0001628
CP3 Project Description Investigation http://purl.obolibrary.org/obo/OBI_0001615 Description*
CP4 Project Relevance Investigation http://purl.obolibrary.org/obo/OBI_0500000 Relevance*
CP5 Sample
Scope
Investigation http://purl.obolibrary.org/obo/OBI_0001884 Sample Scope*
CP6 Target Material Investigation http://purl.obolibrary.org/obo/OBI_0001882 Material*
CP7 Target Capture Investigation http://purl.obolibrary.org/obo/OBI_0001899 Capture*
CP8 Project Method Investigation http://purl.obolibrary.org/obo/OBI_0001896 Methodology*
CP9 Project Objectives Investigation http://purl.obolibrary.org/obo/OBI_0001892 Objective*
CP10 Grant Agency Investigation http://purl.obolibrary.org/obo/OBI_0001942
CP11 Supporting Grants/
Contract ID
Investigation http://purl.obolibrary.org/obo/OBI_0001629 Grant ID
CP12 Publication Citation Investigation http://purl.obolibrary.org/obo/OBI_0001617 PubMed ID; DOI ref_ biomaterial

































*Mandatory NCBI BioProject attributes.
doi:10.1371/journal.pone.0099979.t001
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Table 2. Core Sample Attributes.
Field





Host Characterization http://purl.obolibrary.org/obo/OBI_0001141 host_subject_id host_ subject_id
CS2 Specimen
Category
Pathogen Detection http://purl.obolibrary.org/obo/OBI_0100051 sample_category
CS3 Specimen Source
Species
Host Characterization http://purl.obolibrary.org/obo/OBI_0100026 host* host_taxid
CS4 Species Source
Common Name




Host Characterization http://purl.obolibrary.org/obo/PATO_0000047 host_sex sex
CS6 Specimen Source
Age - Value
Host Characterization http://purl.obolibrary.org/obo/OBI_0001167 host_age age
CS7 Specimen Source
Age - Unit
Host Characterization http://purl.obolibrary.org/obo/UO_0000003 host_age
CS8 Specimen Source
Health Status




Host Characterization http://purl.obolibrary.org/obo/OGMS_0000031 host_disease* disease status
CS10 Specimen Collection
Date
Specimen Isolation http://purl.obolibrary.org/obo/OBI_0001619 collection_date* collection date
CS11 Specimen Collection
Location - Latitude
























Specimen Isolation http://purl.obolibrary.org/obo/OBI_0001616 sample_name*
CS16 Specimen
Type



















Pathogen Characteristic http://purl.obolibrary.org/obo/IDO_0000666 pathogenicity phenotype
CS20 Environmental
Material











Specimen Processing http://purl.obolibrary.org/obo/OBI_0001885 culture_collection source material
identifiers
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C. The Sequencing Assay section includes 10 data fields that are
grouped into four categories describing sample shipment,
sequencing sample preparation, sequencing assay and data
transformation (post-sequencing steps, such as assembly and
annotation) (Table S1 in File S1). Many of these fields would
only be relevant for a subset of sequencing projects and so are
considered optional.
D. The Pathogen Specific section includes data fields that vary
depending on the type of pathogen/vector: bacteria (Table
S2 in File S1) or eukaryotic pathogen/vector (Table S3 in File
S1). (Note that no data fields were identified that would be
applicable for all virus sequencing projects given the large
diversity of virus biology and genomic features, and so no
virus-specific collection was assembled.) This section provides
the possibility of including metadata specific to a particular
pathogen/vector that do not necessarily apply to other types
of pathogens/vectors, for example, extra chromosomal
elements that may apply to some bacteria or eukaryotic
pathogens, bacteria typing method, and malaria parasitemia
measures.
E. Project Specific data fields capture information not included in
the previous sections but which investigators believe add
relevant details about the investigation in certain circum-
stances. Since every project is different, these Project Specific
fields are designed to capture those differences. To facilitate
cross-study comparisons, a repository of Project Specific data
fields is provided to enable interoperability through con-
trolled vocabularies if and when a particular data field is
relevant for a given project (Table S4 in File S1).
Semantic Representation
After the list of terms to be included in the Core Project, Core
Sample, and Sequencing Assay data fields were compiled, they
were then assembled into a semantic network based on OBI and
other OBO Foundry compatible ontologies and relations (Figures 2
and 3). The goal of this process was to define the relationships
between the various data fields and identify any gaps or
inconsistencies that existed in the original list of data fields. For
example, only one temporal data field for any given sequenced
specimen was included in the first draft of Core Sample terms;
however, it quickly became apparent that one time point was
insufficient since a time measurement may be assigned when an
infectious agent was first collected from the specimen source
organism, when the health status of the specimen source was
assessed, when the sample material was extracted from the
specimen, when the sample material was subjected to an
experimental assay, etc. (Figure 3). Indeed, all processes occur
within their own timespan, and their temporal relationships can
have important implications for the interpretation of the resulting
sequence record. Although these temporal (and other) relation-
ships are implied, constructing a formal semantic representation
allowed us to correct similar omissions and clarify meanings that
had previously been unintentionally ambiguous. In the case of
Core Project, similar data fields were identified for each of the
main parties involved – sample providers, assay centers and
bioinformatics centers (Figure 2).
A second effect of this semantic network representation was that
it generated a logical structure that reflects the processes being
performed at various stages of scientific experimentation and data
generation (e.g. specimen isolation, material processing, experi-
mental assay and data processing), thereby delineating the data
categories described above. Upon further examination, we found
that the relationships existing within some of these sub-networks
were not limited to sequencing experiments, thereby making the
data structures for Core Project and Core Sample modular and
reusable for other kinds of assays. Due to their general nature, the
foundational structure of core metadata terms and their process
categories could also be extended to define the relationships that
exist between project-specific metadata terms.
Discussion
Pathogen and vector genomic DNA and cDNA sequences have
been deposited in open access sequence repositories since the
creation of GenBank in the early 1980s [21]. The availability of
genome sequence and related functional data has helped drive the
further development of more specialized resources, like the BRCs,
that facilitate the integration and analysis of these combined data
[16]. The number of sequencing projects has dramatically
increased due to the development of new sequencing technologies,
the availability of computational resources, and the support for
focused sequencing efforts, including those being conducted at
NIAID-funded GSCIDs. The value of these large-scale genome
projects, including the statistical robustness of downstream
analyses, is influenced greatly by the quality of the associated
metadata describing the characteristics of the sample used and the
circumstances surrounding its collection.
The initiative described here focused on assembling an
application standard to collect metadata for pathogen, parasite,
and vector sequences. The working group has interacted with a
broad collection of key stakeholders in the infectious disease
Table 2. Cont.
Field





Specimen Processing http://purl.obolibrary.org/obo/OBI_0001900 culture_collection source material
identifiers
CS24 Comments Specimen Comments http://purl.obolibrary.org/obo/OBI_0001898
CS25 Specimen Collector
Name
Specimen Isolation http://purl.obolibrary.org/obo/OBI_0001895 collected_by*
CS26 Specimen Collector’s
Institution




Specimen Isolation http://purl.obolibrary.org/obo/OBI_0001890 specimen_collector’s_
institution
*Mandatory NCBI BioSample attributes in the ‘‘Pathogen: clinical or host-associated’’ version 1.0 package.
doi:10.1371/journal.pone.0099979.t002
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Figure 2. Semantic Network of the Core Project Data Fields. A semantic representation of the entities relevant to describe infectious disease
projects based on the OBI and other OBO Foundry ontologies is shown. Distinctions are made between material entities (blue outlines), information
entities and qualities (black outlines), and processes (red outlines). Entities are connected by standard semantic relations, in italic. The subset of
entities selected as Core Project fields are noted with ovals containing the respective Field ID. For example, both the ‘‘Project Title’’ (CP1) and ‘‘Project
ID’’ (CP2) denote an OBI:Investigation; the ‘‘Project Description’’ (CP3) is_about the same OBI:Investigation.
doi:10.1371/journal.pone.0099979.g002
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research, genome sequencing, bioinformatics, and data standards
communities to develop this application standard to ensure the
continued relevance and usefulness of data standards. GSCID/
BRC projects are now required to adhere to the metadata
standard collections developed herein. Consequently, consistent
metadata fields will accompany all viral, bacterial, and eukaryotic
pathogen or vector samples currently being sequenced and
annotated by the GSCIDs. All allowable metadata will be
submitted to the appropriate public repository, with the remaining
being made publicly available in the respective BRC. Current
projects being undertaken at the GSCIDs involve diverse
pathogens and vectors representing a wide range of geographic
origins, temporal origins, and disease outcomes. Metadata
collected in association with these efforts will be particularly
important given the need to associate such population variation
data with specific sample phenotypes that characterize ecology,
behavior, physiology, genetic diversity, antigenic and allelic
variation, as well as vector-pathogen interactions.
Relationship to other Data Standards Initiatives
It is important to recognize that this application standard does
not re-invent or recapitulate what is already available in other
Figure 3. Semantic Network of the Core Sample Data Fields. A semantic representation of the entities relevant to describe infectious disease
samples based on the OBI and other OBO Foundry ontologies is shown. Distinctions are made between material entities (blue outlines), information
entities and qualities (black outlines), and processes (red outlines). Entities are connected by standard semantic relations, in italic. The subset of
entities selected as Core Sample fields are noted with ovals containing the respective Field ID. For example, the OBI:organism has_quality ‘‘Specimen
Source Gender’’ (CS5), which is equivalent to the PATO:biological sex, and has_quality PATO:age, and has_quality ‘‘Specimen Source Health Status’’
(CS8), which is equivalent to PATO:organismal status. PATO:age is_quality_measured_as OBI:age since birth measurement datum, which
has_measurement_value ‘‘Specimen Source Age – Value’’ (CS6) and has_measurement_unit_label ‘‘Specimen Source Age – Unit’’ (CS7).
doi:10.1371/journal.pone.0099979.g003
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standards. Rather, our efforts focused on the harmonization and
inter-compatibility with existing resources such as OBI, MIxS, and
BioProject/BioSample [17,20,22,23]. Our effort at harmonization
is reflected in the fact that our Core Project and Core Sample
collections include mappings to OBO foundry IDs and equivalent
terms existing in OBI, BioSample/BioProject, and MIxS. This
harmonization effort will allow data submitters to represent their
sequencing metadata in a single schema that will be compatible
with representations used by many other bioinformatics resources,
including the BioSample/BioProject registrations required for
GenBank submissions.
Value of Modeling Semantic Representation
The representation of metadata using an ontology-driven
semantic framework was a relatively novel feature of this
approach. Assembling the data elements into a semantic
framework provides interoperability between databases, minimizes
the loss of information when transferring or converting between
standards, and allows ontology-driven inference engines to take
full advantage of this newly assimilated data as it is applied to other
emerging ‘‘-omics’’ technologies. The semantic framework adopt-
ed for this purpose was largely based on the Ontology of
Biomedical Investigation (OBI) [17], a newly-admitted OBO
Foundry ontology focused on the representation of experimental
planned processes and related entities [18]. OBI has been built on
the high-level framework provided by the Basic Formal Ontology
(BFO) that divides the universe into three main categories –
occurrents (processes, with definable starts and ends), independent
continuants (objects, that exist throughout time) and dependent
continuants (characteristics of those objects) [24]. The semantic
modeling described here enabled the visualization of the entire
experimental workflow, from specimen collection to sequence
submission, with terms of the component processes and partici-
pants involved.
Tools for Standards-compliant Data Submission
In order to make it relatively easy for data providers to comply
with the developed GSCID/BRC Project and Sample Application
Standard, three different tools have been developed. First, each of
the BRCs is making data submission spreadsheets available in
Excel formats through their websites (e.g. http://www.fludb.org/
brc/datastd and http://www.viprbrc.org/brc/datastd) since most
potential data submitters are comfortable with using Excel
spreadsheets for the capture of sample-level metadata. Second,
an electronic data capture tool called O-Meta developed at the J.
Craig Venter Institute has been configured to comply with the
GSCID/BRC Project and Sample Application Standard and
made freely available through GitHub at https://github.com/
movence/ometa. Third, the PATRIC BRC is exploring the use of
a Google spreadsheet widget called OntoMaton (https://github.
com/ISA-tools/OntoMaton) that will enable the users to directly
access relevant ontology terms using the ISA-Tab framework for
metadata submission [25,26]. This solution allows pre-defined
ontology terms to be searched for and inserted in real-time via the
NCBO BioPortal and the Ontology Lookup Service at the
European Bioinformatics Institute [27–29]. These approaches
should provide potential data submitters with user-friendly tools
for both local metadata storage and metadata submission that are
compliant with the developed data standard.
Next Steps/Future Development
Although considerable discussion and revision went into the
development of the released version 1.3 of the metadata standard, it
was also recognized that ongoing refinement would likely be necessary
to address future changes in the infectious disease field. Therefore,
community members will be able to provide input on suggested
enhancements to the submission templates through the GitHub
repository at https://github.com/GSCID-BRC-Metadata-Standard-
WG/GSCID-BRC-Project-and-Sample-Application-Standard. All re-
quests will be periodically reviewed by the GSCID-BRC Metadata
Working Group and updated versions of the templates released as
appropriate.
Early in the process of developing the current application
standard, we came to the realization that standardizing the
representation of metadata relating to clinical encounters of
human-derived samples would be relatively complex. A wide
range of signs, symptoms, laboratory test results, and physical
exam assessments could potentially be relevant while patient
privacy and re-identification risk also have to be factored in. Since
these issues would only be relevant for the subset of samples
derived from human hosts, they do not fall into the category of
core metadata fields. For these reasons, a separate working group
was assembled to specifically deal with how to approach the
standardization of clinical metadata. When completed, the
standardized clinical metadata fields will be reported in a separate
publication, and will be treated as project-specific fields for use on
a case-by-case basis.
Conclusions
The development of metadata standards for use by all GSCID
sequencing projects will allow for a consistent representation of
these data in the BRC resources and will also serve as a paradigm
for other pathogen sequencing projects, thus supporting further
interoperability. By capturing key information about pathogen
isolates for the genome sequences being deposited in public data
repositories in a consistent way, the standardized metadata will
allow the pathogen research community to identify all represen-
tatives of genome sequences that match their particular interests,
which will in turn allow them to perform statistically meaningful,
and biologically relevant comparative genomics analysis. The end
result will be a wealth of information about sequenced pathogens
and vectors that can be used for more accurate downstream
analysis.
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